Cypress Capital Group Becton Dickinson & CO Transaction History

Cypress Capital Group

$879 Million
Q3 2024

A detailed history of Cypress Capital Group transactions in Becton Dickinson & CO stock. As of the latest transaction made, Cypress Capital Group holds 3,833 shares of BDX stock, worth $858,592. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,833

Previous 3,948 2.91%

Holding current value

$858,592

Previous $922,000 0.22%

% of portfolio

0.11%

Previous 0.11%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$221.47 - $242.41 $25,469 - $27,877	-115 Reduced 2.91%	3,833 $924,000
Q2 2024 Jul 25, 2024	BUY	$225.07 - $246.17 $78,774 - $86,159	350 Added 9.73%	3,948 $922,000
Q1 2024 May 08, 2024	BUY	$233.45 - $247.73 $3,501 - $3,715	15 Added 0.42%	3,598 $890,000
Q4 2023 Jan 24, 2024	SELL	$232.24 - $267.23 $46,448 - $53,446	-200 Reduced 5.29%	3,583 $873,000
Q3 2023 Nov 02, 2023	SELL	$254.9 - $283.59 $12,999 - $14,463	-51 Reduced 1.33%	3,783 $978,000
Q2 2023 Jul 26, 2023	SELL	$238.39 - $265.32 $19,786 - $22,021	-83 Reduced 2.12%	3,834 $1.01 Million
Q1 2023 May 04, 2023	SELL	$229.71 - $259.35 $15,849 - $17,895	-69 Reduced 1.73%	3,917 $969,000
Q4 2022 Feb 14, 2023	SELL	$218.29 - $256.91 $509,925 - $600,141	-2,336 Reduced 36.95%	3,986 $1.01 Million
Q3 2022 Nov 04, 2022	SELL	$51.03 - $264.23 $32,199 - $166,729	-631 Reduced 9.08%	6,322 $1.41 Million
Q2 2022 Jul 26, 2022	BUY	$234.74 - $275.42 $474,879 - $557,174	2,023 Added 41.03%	6,953 $1.71 Million
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $93,557 - $103,864	-384 Reduced 7.23%	4,930 $1.31 Million
Q4 2021 Feb 15, 2022	BUY	$230.08 - $250.94 $440,833 - $480,801	1,916 Added 56.39%	5,314 $1.34 Million
Q4 2020 Jan 12, 2021	SELL	$221.92 - $245.94 $3,328 - $3,689	-15 Reduced 0.44%	3,398 $850,000
Q3 2020 Oct 08, 2020	SELL	$215.77 - $276.76 $2,805 - $3,597	-13 Reduced 0.38%	3,413 $794,000
Q2 2020 Jul 10, 2020	SELL	$219.9 - $263.41 $2,638 - $3,160	-12 Reduced 0.35%	3,426 $820,000
Q3 2019 Oct 10, 2019	SELL	$230.58 - $256.08 $35,739 - $39,692	-155 Reduced 4.31%	3,438 $870,000
Q2 2019 Aug 15, 2019	SELL	$217.4 - $246.08 $85,873 - $97,201	-395 Reduced 9.9%	3,593 $905,000
Q1 2019 May 14, 2019	BUY	$206.05 - $248.17 $252,411 - $304,008	1,225 Added 44.34%	3,988 $996,000
Q4 2018 Feb 19, 2019	SELL	$204.73 - $257.93 $409 - $515	-2 Reduced 0.07%	2,763 $623,000
Q3 2018 Nov 15, 2018	SELL	$233.07 - $256.0 $104,881 - $115,200	-450 Reduced 14.0%	2,765 $722,000
Q2 2018 Aug 15, 2018	SELL	$208.1 - $233.85 $108,420 - $121,835	-521 Reduced 13.95%	3,215 $770,000
Q1 2018 May 21, 2018	SELL	$205.46 - $240.27 $32,873 - $38,443	-160 Reduced 4.11%	3,736 $809,000
Q4 2017 Feb 14, 2018	SELL	$189.0 - $222.64 $5,481 - $6,456	-29 Reduced 0.74%	3,896 $834,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,925	3,925 $766,000

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Account

Cypress Capital Group Becton Dickinson & CO Transaction History